418
Views
125
CrossRef citations to date
0
Altmetric
Original Research Papers

Konjac Supplement Alleviated Hypercholesterolemia and Hyperglycemia in Type 2 Diabetic Subjects—A Randomized Double-Blind Trial

, RD, PhD, , MD, PhD, , MD, , PhD & , MS
Pages 36-42 | Received 26 Jul 2001, Accepted 07 Oct 2002, Published online: 19 Jun 2013
 

Abstract

Objectives: The present study was designed to evaluate effects of konjac glucomannan (KGM) supplement (3.6 g/day) for 28 days on blood lipid and glucose levels in hyperlipidemic type 2 diabetic patients and the possible mechanism for the reductions in blood lipid levels.

Methods: Twenty-two diabetic subjects (age 64.2 + 8.4 years, BMI 25.5 + 3.2 kg/m2) with elevated blood cholesterol levels (fasting glucose between 6.7–14.4 mmol/L), but currently not taking lipid-lowering medication, were recruited to participate in a two 28-day period, randomized, double-blind, crossover clinical trial. Fasting blood samples drawn on the initial and final days of each period were determined for plasma lipids and glucose levels. Feces collected at the end of each experimental period were analyzed for neutral sterol and bile acid contents.

Results: Compared with placebo, KGM effectively reduced plasma cholesterol (11.1%, p = 0.0001, adjusted α = 0.006), LDL-cholesterol (20.7%, p = 0.0004, adjusted α = 0.006), total/HDL cholesterol ratio (15.6%, p = 0.0005, adjusted α = 0.007), ApoB (12.9%, p = 0.0001, adjusted α = 0.006) and fasting glucose (23.2%, p = 0.002, adjusted α = 0.008). Plasma triglyceride, HDL-cholesterol, LDL/HDL cholesterol, postprandial glucose and body weight were not significant after adjustment by the Bonferroni-Hochberg procedure. Fecal neutral sterol and bile acid concentrations were increased by 18.0% (p = 0.004) and 75.4% (p < 0.001), respectively, with KGM supplement.

Conclusions: The KGM supplement improved blood lipid levels by enhancing fecal excretion of neutral sterol and bile acid and alleviated the elevated glucose levels in diabetic subjects. KGM could be an adjunct for the treatment of hyperlipidemic diabetic subjects.

This study is funded by the National Science Council grant NSC 89-2320-B-040-037. The supply of konjac powder by Fukar International Ltd., Taipei, Taiwan, is appreciated.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 139.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.